Amanda Regio Pereira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amanda Regio Pereira has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Pascale Guitera
Melanoma Institute Australia The University of Sydney Sydney New South Wales Australia
5 shared publications - Helena Collgros
Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia
4 shared publications - Richard Scolyer
Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia
4 shared publications - Clarissa Lin Yasuda
Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Departamento de Neurologia, Campinas SP, Brazil
3 shared publications - Fernando Cendes
Department of Neurology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil
3 shared publications Milvia Maria Simões e Silva Enokihara
Universidade Federal de São Paulo, Brazil
3 shared publications
Latest Publications
- 30 November 2023
- Published by S. Karger AG in Dermatology
- Vol. 240 (1) , 132-141
Dermoscopy of Lentiginous Melanomas and Equivocal Benign Pigmented Macules of the Scalp: A Case-Control Multicentric Study
Introduction: Although the dermoscopic features of facial lentiginous melanomas (LM), including lentigo maligna and lentigo maligna melanoma, have been extensively studied, the literature about those located on the scalp is scarce. This study aims to describe the dermoscopic features of scalp LM and assess the diagnostic accuracy of dermoscopy to discriminate them from equivocal benign pigmented macules. Methods: Consecutive cases of scalp LM and histopathology-proven benign but clinically equivocal pigmented macules (actinic keratoses, solar lentigos, seborrhoeic keratoses, and lichen planus-like keratoses) from four referral centres were included. Dermoscopic features were analysed by two blinded experts. The diagnostic performance of a predictive model was assessed. Results: 56 LM and 44 controls were included. Multiple features previously described for facial and extrafacial LM were frequently identified in both groups. Expert’s sensitivity to diagnose scalp LM was 76.8% (63.6–87.0) and 78.6% (65.6–88.4), with specificity of 54.5% (38.9–69.6) and 56.8% (41.0–71.7), and fair agreement (kappa coefficient 0.248). The strongest independent predictors of malignancy were (OR, 95% CI) chaos of colour (15.43, 1.48–160.3), pigmented reticular lines (14.96, 1.68–132.9), increased density of vascular network (3.45, 1.09–10.92), and perifollicular grey circles (2.89, 0.96–8.67). The predictive model achieved 85.7% (73.8–93.6) sensitivity, 61.4% (45.5–75.6) specificity, and 81.5 (73.0–90.0) area under curve to discriminate benign and malignant lesions. A diagnostic flowchart was proposed, which should improve the diagnostic performance of dermoscopy. Conclusion: Both facial and extrafacial dermoscopic patterns can be identified in scalp LM, with considerable overlap with benign pigmented macules, leading to low specificity and interobserver agreement on dermoscopy.
- 30 November 2023
- Published by S. Karger AG in Dermatology
- Vol. 240 (1) , 132-141
Dermoscopy of Lentiginous Melanomas and Equivocal Benign Pigmented Macules of the Scalp: A Case-Control Multicentric Study
Introduction: Although the dermoscopic features of facial lentiginous melanomas (LM), including lentigo maligna and lentigo maligna melanoma, have been extensively studied, the literature about those located on the scalp is scarce. This study aims to describe the dermoscopic features of scalp LM and assess the diagnostic accuracy of dermoscopy to discriminate them from equivocal benign pigmented macules. Methods: Consecutive cases of scalp LM and histopathology-proven benign but clinically equivocal pigmented macules (actinic keratoses, solar lentigos, seborrhoeic keratoses, and lichen planus-like keratoses) from four referral centres were included. Dermoscopic features were analysed by two blinded experts. The diagnostic performance of a predictive model was assessed. Results: 56 LM and 44 controls were included. Multiple features previously described for facial and extrafacial LM were frequently identified in both groups. Expert’s sensitivity to diagnose scalp LM was 76.8% (63.6–87.0) and 78.6% (65.6–88.4), with specificity of 54.5% (38.9–69.6) and 56.8% (41.0–71.7), and fair agreement (kappa coefficient 0.248). The strongest independent predictors of malignancy were (OR, 95% CI) chaos of colour (15.43, 1.48–160.3), pigmented reticular lines (14.96, 1.68–132.9), increased density of vascular network (3.45, 1.09–10.92), and perifollicular grey circles (2.89, 0.96–8.67). The predictive model achieved 85.7% (73.8–93.6) sensitivity, 61.4% (45.5–75.6) specificity, and 81.5 (73.0–90.0) area under curve to discriminate benign and malignant lesions. A diagnostic flowchart was proposed, which should improve the diagnostic performance of dermoscopy. Conclusion: Both facial and extrafacial dermoscopic patterns can be identified in scalp LM, with considerable overlap with benign pigmented macules, leading to low specificity and interobserver agreement on dermoscopy.
- 29 March 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (7) , E583-E585
Reflectance confocal microscopy – a non‐invasive tool for monitoring systemic treatment response in stage III unresectable primary scalp melanoma
- 29 March 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (7) , E583-E585
Reflectance confocal microscopy – a non‐invasive tool for monitoring systemic treatment response in stage III unresectable primary scalp melanoma
- Open Access
- 15 February 2022
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 47 (5) , 932-941
Dermoscopic features and screening strategies for the detection of small‐diameter melanomas
Background If 70% of cutaneous melanomas develop de novo, small-diameter or tiny lesions are expected to represent the earliest manifestation of most melanomas. Objectives To describe the clinical, histopathological and dermoscopic features of tiny melanomas; and to investigate the impact of imaging tools, including total body photography (TBP) and sequential digital dermoscopy imaging (SDDI) in their detection. Methods Consecutive melanomas diagnosed over 2 years in a referral centre were retrospectively included. Diameter ≤5mm on dermoscopy defined tiny melanomas. Dermoscopic features and performance of four methods were evaluated. Results 86/312 (27.6%) of the included melanomas measured ≤5mm. They were invasive in 44.2%. Tiny melanomas were more frequently excised for being new and/or changing compared to non-tiny melanomas (77.9% vs. 50.9%; P<.0001). Half of the tiny melanomas would have been missed by the dermoscopic 7-point checklist (48.2%) or the 3-point checklist (49.4%). Menzies’ method and the revised pattern analysis correctly identified respectively 65.9% and 63.5% of the tiny melanomas. The most frequent positive features for tiny melanomas were asymmetry in structure or colour (77.6%), brown dots (65.9%), irregular dots and globules (76.5%) and atypical pigment network (44.7%). Dermoscopic features predictive of invasion in tiny melanomas were (OR, 95%CI) atypical vascular pattern (26.5, 1.5-475.5, P=.002), shiny white lines (12.4, 0.7-237.8, P=0.04) and grey/blue structures (3.7, 1.3-10.5, P=0.01). Conclusions Tiny melanomas are frequently invasive and represent a clinical, dermoscopic and histopathological challenge. Dermoscopy alone has suboptimal diagnostic accuracy. Early diagnosis relies on the detection of new or changing lesions aided by TBP and SDDI.
- 15 February 2022
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 47 (5) , 932-941
Open AccessDermoscopic features and screening strategies for the detection of small‐diameter melanomas
Background If 70% of cutaneous melanomas develop de novo, small-diameter or tiny lesions are expected to represent the earliest manifestation of most melanomas. Objectives To describe the clinical, histopathological and dermoscopic features of tiny melanomas; and to investigate the impact of imaging tools, including total body photography (TBP) and sequential digital dermoscopy imaging (SDDI) in their detection. Methods Consecutive melanomas diagnosed over 2 years in a referral centre were retrospectively included. Diameter ≤5mm on dermoscopy defined tiny melanomas. Dermoscopic features and performance of four methods were evaluated. Results 86/312 (27.6%) of the included melanomas measured ≤5mm. They were invasive in 44.2%. Tiny melanomas were more frequently excised for being new and/or changing compared to non-tiny melanomas (77.9% vs. 50.9%; P<.0001). Half of the tiny melanomas would have been missed by the dermoscopic 7-point checklist (48.2%) or the 3-point checklist (49.4%). Menzies’ method and the revised pattern analysis correctly identified respectively 65.9% and 63.5% of the tiny melanomas. The most frequent positive features for tiny melanomas were asymmetry in structure or colour (77.6%), brown dots (65.9%), irregular dots and globules (76.5%) and atypical pigment network (44.7%). Dermoscopic features predictive of invasion in tiny melanomas were (OR, 95%CI) atypical vascular pattern (26.5, 1.5-475.5, P=.002), shiny white lines (12.4, 0.7-237.8, P=0.04) and grey/blue structures (3.7, 1.3-10.5, P=0.01). Conclusions Tiny melanomas are frequently invasive and represent a clinical, dermoscopic and histopathological challenge. Dermoscopy alone has suboptimal diagnostic accuracy. Early diagnosis relies on the detection of new or changing lesions aided by TBP and SDDI.
- 18 January 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (6) , E445-E448
Successful treatment of eruptive keratoacanthomas with actitretin for patients on checkpoint inhibitor immunotherapy
- 18 January 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 36 (6) , E445-E448
Successful treatment of eruptive keratoacanthomas with actitretin for patients on checkpoint inhibitor immunotherapy
- 26 October 2021
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 63 (1) , 105-109
Complex melanoma of the scalp: Diagnosis and management aided by confocal microscopy
Melanomas of lentigo maligna subtype are a steadily growing problem and frequently represent a clinical challenge. A case is reported of a complex melanoma of the scalp illustrating the critical role of confocal microscopy for optimal diagnosis and management.
- 26 October 2021
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 63 (1) , 105-109
Complex melanoma of the scalp: Diagnosis and management aided by confocal microscopy
Melanomas of lentigo maligna subtype are a steadily growing problem and frequently represent a clinical challenge. A case is reported of a complex melanoma of the scalp illustrating the critical role of confocal microscopy for optimal diagnosis and management.
- 31 October 2020
- Published by Wiley in International Journal of Dermatology
- Vol. 60 (3) , 340-346
Melanomas of the scalp: is hair coverage preventing early diagnosis?
Background: Scalp melanomas are usually thicker and show worse prognosis than other sites and other head and neck melanomas. One hypothesis to explain this aggressive behavior could be diagnosis delay attributed to hair concealment of lesions.Methods: Primary melanomas of the scalp diagnosed over two decades at four reference centers in Australia and Italy were included. Hair coverage and visibility of the lesions were assessed on preoperative photographic documentation by two investigators and correlated with some prognostic factors (Breslow thickness, mitotic rate, and ulceration). Patients records and pathology reports provided clinical and histological data.Results: The majority of 113 melanomas included were located on easily visible areas of the scalp – hairless scalp (49%) or hairline (15%). The remaining ones (36%), considered to be hair‐covered, showed more frequently thinning of hair (63%) than a dense hair coverage (37%). Melanomas of “hairy scalps” were more frequently invasive (81%) and had higher median Breslow (0.8 ± 1.3 mm) than those arising on bald scalps or areas with thinning of hair (43%; 0 ± 0.6 mm), P = 0.004. However, when considering only the invasive cases (n = 55), Breslow thickness and mitotic rate were not statistically different between concealed and easily visible areas. Melanomas detected by a doctor were thinner than those first noticed by the patient, relatives, or a hairdresser (P < 0.001).Conclusions: Most scalp melanomas arose on easily visible areas, which are more prone to ultraviolet damage. Hair‐covered ones, despite rare, could be overlooked during examination. Proactive screening of the scalp area should be encouraged.
- 31 October 2020
- Published by Wiley in International Journal of Dermatology
- Vol. 60 (3) , 340-346
Melanomas of the scalp: is hair coverage preventing early diagnosis?
Background: Scalp melanomas are usually thicker and show worse prognosis than other sites and other head and neck melanomas. One hypothesis to explain this aggressive behavior could be diagnosis delay attributed to hair concealment of lesions.Methods: Primary melanomas of the scalp diagnosed over two decades at four reference centers in Australia and Italy were included. Hair coverage and visibility of the lesions were assessed on preoperative photographic documentation by two investigators and correlated with some prognostic factors (Breslow thickness, mitotic rate, and ulceration). Patients records and pathology reports provided clinical and histological data.Results: The majority of 113 melanomas included were located on easily visible areas of the scalp – hairless scalp (49%) or hairline (15%). The remaining ones (36%), considered to be hair‐covered, showed more frequently thinning of hair (63%) than a dense hair coverage (37%). Melanomas of “hairy scalps” were more frequently invasive (81%) and had higher median Breslow (0.8 ± 1.3 mm) than those arising on bald scalps or areas with thinning of hair (43%; 0 ± 0.6 mm), P = 0.004. However, when considering only the invasive cases (n = 55), Breslow thickness and mitotic rate were not statistically different between concealed and easily visible areas. Melanomas detected by a doctor were thinner than those first noticed by the patient, relatives, or a hairdresser (P < 0.001).Conclusions: Most scalp melanomas arose on easily visible areas, which are more prone to ultraviolet damage. Hair‐covered ones, despite rare, could be overlooked during examination. Proactive screening of the scalp area should be encouraged.
- Open Access
- 1 December 2018
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 109 (10) , 900-907
Inpatient Dermatology Consultations in Renal Transplant Recipients
- 1 December 2018
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 109 (10) , 900-907
Open AccessInpatient Dermatology Consultations in Renal Transplant Recipients
- 9 October 2018
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 60 (2) , 118-125
The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population‐based data on diagnosis and management
Background/Objectives: There are limited population‐based data documenting the incidence and management of lentigo maligna (LM) and invasive lentigo maligna melanoma (LMM). We report the data on occurrence and management of LM and LMM in an Australian population.Methods: Prospective collection of incidence and clinician‐reported management of melanoma in situ (MIS; n = 450, capped) and localised invasive melanoma (n = 3251) notified to the New South Wales Cancer Registry over 12‐months in 2006–2007.Results: The estimated annual incidence of all MIS was 27.0 per 100 000 (LM 12.2, non‐LM MIS 5.9 and unclassified MIS 9.0). Patients with LM or LMM were on average approximately 10 years older than those with other melanoma subtypes (P < 0.001). The head and neck was the location of 59% of LM, 44% of LMM and P < 0.001). The majority of LM and LMM were treated only by specialists. Diagnostic partial biopsies were more frequent for LM and LMM than for other melanoma subtypes, and primary care physicians were more likely than specialists to do a punch partial biopsy than a shave biopsy. The reported median definitive excision margin for LM was 5.0 mm compared with 7.2 mm for non‐LM MIS (P = 0.001).Conclusions: In this Australian population, LM was twice as frequent as other types of MIS. Improved strategies for diagnosis and management are required.
- 9 October 2018
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 60 (2) , 118-125
The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: Population‐based data on diagnosis and management
Background/Objectives: There are limited population‐based data documenting the incidence and management of lentigo maligna (LM) and invasive lentigo maligna melanoma (LMM). We report the data on occurrence and management of LM and LMM in an Australian population.Methods: Prospective collection of incidence and clinician‐reported management of melanoma in situ (MIS; n = 450, capped) and localised invasive melanoma (n = 3251) notified to the New South Wales Cancer Registry over 12‐months in 2006–2007.Results: The estimated annual incidence of all MIS was 27.0 per 100 000 (LM 12.2, non‐LM MIS 5.9 and unclassified MIS 9.0). Patients with LM or LMM were on average approximately 10 years older than those with other melanoma subtypes (P < 0.001). The head and neck was the location of 59% of LM, 44% of LMM and P < 0.001). The majority of LM and LMM were treated only by specialists. Diagnostic partial biopsies were more frequent for LM and LMM than for other melanoma subtypes, and primary care physicians were more likely than specialists to do a punch partial biopsy than a shave biopsy. The reported median definitive excision margin for LM was 5.0 mm compared with 7.2 mm for non‐LM MIS (P = 0.001).Conclusions: In this Australian population, LM was twice as frequent as other types of MIS. Improved strategies for diagnosis and management are required.
- Open Access
- 1 October 2016
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 91 (5 suppl 1) , 35-38
Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis
Linear IgA dermatosis is a rare subepidermal autoimmune blistering disease characterized by linear deposition of IgA along the basement membrane zone. In the last three decades, many different drugs have been associated with the drug-induced form of the disease, especially vancomycin. We report a case of vancomycin-induced linear IgA disease mimicking toxic epidermal necrolysis. The aim of this work is to emphasize the need to include this differential diagnosis in cases of epidermal detachment and to review the literature on the subject and this specific clinical presentation.
- 1 October 2016
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 91 (5 suppl 1) , 35-38
Open AccessVancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis
Linear IgA dermatosis is a rare subepidermal autoimmune blistering disease characterized by linear deposition of IgA along the basement membrane zone. In the last three decades, many different drugs have been associated with the drug-induced form of the disease, especially vancomycin. We report a case of vancomycin-induced linear IgA disease mimicking toxic epidermal necrolysis. The aim of this work is to emphasize the need to include this differential diagnosis in cases of epidermal detachment and to review the literature on the subject and this specific clinical presentation.
- Open Access
- 1 June 2015
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 90 (3 suppl 1) , 165-167
New drugs, new challenges for dermatologists: mucocutaneous ulcers secondary to everolimus
Everolimus, a mammalian target of rapamycin inhibitor, is an emerging drug, which is being increasingly applied in oncology and solid organ transplantation. Oral ulcers are a frequent side effect associated with this immunosupressor. We report the case of a renal transplant recipient who developed disfiguring oral and perianal ulcers secondary to everolimus's toxicity. This is probably the first report of perianal involvement. Dermatologists need to be aware of the potential mucocutaneous adverse effects related to these new drugs that are becoming evermore common in our clinical practice.
- 1 June 2015
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 90 (3 suppl 1) , 165-167
Open AccessNew drugs, new challenges for dermatologists: mucocutaneous ulcers secondary to everolimus
Everolimus, a mammalian target of rapamycin inhibitor, is an emerging drug, which is being increasingly applied in oncology and solid organ transplantation. Oral ulcers are a frequent side effect associated with this immunosupressor. We report the case of a renal transplant recipient who developed disfiguring oral and perianal ulcers secondary to everolimus's toxicity. This is probably the first report of perianal involvement. Dermatologists need to be aware of the potential mucocutaneous adverse effects related to these new drugs that are becoming evermore common in our clinical practice.